Internship

Technology Rotational Development Program Internship

Summer 2025

Confirmed live in the last 24 hours

Bristol-Myers Squibb

Bristol-Myers Squibb

10,001+ employees

Develops and delivers biopharmaceutical medicines

Biotechnology
Healthcare

No H1B Sponsorship

Princeton, NJ, USA

Site-essential roles require 100% onsite presence.

Category
Data Science
Data Engineering
Data & Analytics
Required Skills
Financial analysis
Data Analysis
Requirements
  • Master of Business Administration (MBA), Master of Information Systems, or relevant Master program with graduation scheduled for Spring/Summer 2026
  • Minimum of 3 years of relevant digital, technology, or other relevant industry experience
  • Legally authorized to work in the United States on a full-time basis without the need for sponsorship for an employment visa now or in the future
  • Understanding of how to examine, assess, and provide innovative solutions to business issues
  • Ability to draw conclusions from complex situations, then recommend and execute a course of action in a timely manner
  • Demonstrated leadership experience through any of the following: professional work, student organizations, professional organizations, and community involvement
  • Excellent written and verbal communication skills with the ability to organize and present ideas in a convincing and compelling manner to small or large audiences at multiple levels within the organization
  • Project Management, Analytics, Business Analysis, Business Case Development, Process Redesign & Continuous Improvement, Quality Mindset & Performance Measurement, Financial Analysis, Change Management, Design Thinking
Responsibilities
  • Learn and obtain expertise in technical and non-technical domains
  • Build a network throughout the IT organization, including exposure and mentorship with senior IT leaders and current members from the Technology Rotational Development Program (IT RDP)
  • Participate in events on key biopharma business and technology topics with senior leaders
  • Attend Team building and networking events across the company and with interns from across various functions

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, particularly in oncology, immunology, and cardiovascular health. The company conducts extensive research and development to create new drugs, which are then sold after receiving regulatory approval. BMS also produces generic drugs that are affordable alternatives to their innovative medicines, ensuring they meet the same quality and safety standards. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, as well as its commitment to sustainability and corporate responsibility. The company's goal is to improve patient outcomes by providing access to effective and affordable healthcare solutions.

Company Stage

IPO

Total Funding

$33.7B

Headquarters

New York City, New York

Founded

1887

Simplify Jobs

Simplify's Take

What believers are saying

  • BMS's involvement in Nobel Prize-winning immunology research underscores its leadership in groundbreaking scientific advancements.
  • The robust pipeline of molecular glues and other innovative therapies promises significant revenue growth and market expansion.
  • Recognition in the Dow Jones Sustainability Index North America highlights BMS's commitment to corporate responsibility and sustainability, enhancing its reputation and stakeholder trust.

What critics are saying

  • The termination of strategic collaborations, such as with Eisai, could impact BMS's ability to bring new therapies to market efficiently.
  • Ongoing layoffs and restructuring efforts may lead to decreased employee morale and potential disruptions in operations.

What makes Bristol-Myers Squibb unique

  • Bristol Myers Squibb's dual focus on innovative and generic medicines allows it to cater to a broad spectrum of healthcare needs, unlike competitors who may focus solely on one area.
  • Their commitment to sustainability and ESG goals sets them apart in the biopharmaceutical industry, appealing to socially conscious investors and stakeholders.
  • BMS's extensive R&D investment in oncology, immunology, and cardiovascular diseases positions it as a leader in developing cutting-edge treatments for serious diseases.

Help us improve and share your feedback! Did you find this helpful?